Copyright © 2019 EnBiotix, Inc.. All Rights Reserved

The EnBiotix Board of Directors brings together over a century of combined biotech management and executive experience

Jeffrey Wager, M.D., Chairman

Jeffrey Wager has over 25 years of senior operating experience in the life sciences.  For his full bio, please see the Management Team page

Dennis Ausiello, M.D., Director

Dennis A. Ausiello, MD, was the Jackson Professor of Clinical Medicine at Harvard Medical School, Chief of Medicine and Physician-in-Chief at Massachusetts General Hospital (MGH).  A nationally recognized leader in academic medicine, Ausiello was elected to the Institute of Medicine of the National Academy of Science in 1999 and the American Academy of Arts and Sciences in 2003. He has written for the New York Times, the Wall Street Journal and the Boston Globe on health subjects, including human genetics, clinical trials and the relationship between the academy and industry.  He also sits on the Board of Directors of Seres Therapeutics and Pfizer, Inc., where he is lead director and chairs Pfizer’s Science and Technology Committee.

Dan Hartman, M.D., Director

Dan Hartman, M.D. joined the Bill and Melinda Gates Foundation in 2012 as Director of Integrated Development and where he also leads the Foundation’s malaria programs globally.   Dr. Hartman has extensive management and pharmaceutical experience and joined the Foundation after four years as President and CEO of Great Lakes Development Inc.–a consulting company providing strategic and operational support for early drug development projects. Previously, Dr. Hartman served as Senior Vice President of Product Development at deCODE genetics, Executive Director of Pfizer Global Research and Development, and Vice President of Global Clinical Development at Esperion Therapeutics. He is an advisor to the NIH and a past president and board member of the American Society of Clinical Pharmacology and Therapeutics.

RG

Roberto Guttmann, Director

Roberto Guttmann was the founder & CEO of United Medical (Brazil), which in 2014 was acquired by Grupo Biotoscana SL (primarily owned by Advent International and Essex Woodlands).  That acquisition made Biotoscana the largest PE-packed specialty pharma company in Latin America, with annual revenues over $250M.  Roberto also has invested in and sits on the boards of Medecell, Steri-Pharma, and others.

Knudson

Dave Knudson, Observer

Dave Knudson is Senior Vice President and Chief Legal Counsel at United National Corporation, where he provides legal and advisory services to the company. Prior to this role, he served as Sr. Vice President – Strategic Advisor for Sanford Health, the largest rural not-for-profit healthcare system in the country. He also practiced law for 35 years at Davenport, Evans, Hurwitz and Smith in Sioux Falls, focusing on healthcare, banking and corporate transactions. Throughout his career as a lawyer and advisor, Dave has worked closely with Mr. Denny Sanford, founder and chairman of United National Corporation and benefactor of Sanford Health, to organize more than $1.5 billion in charitable gifts to various non-profits. Dave has a long-time interest in public service. He was Chief of Staff to South Dakota Governor Bill Janklow in 1995 and 1999, served four terms in the South Dakota State Senate, and served as the Senate Majority Leader from 2007 to 2010. He ran unsuccessfully in the 2010 Republican primary for Governor of South Dakota. He also served on the board of several organizations, including the Sioux Falls Development Foundation and the Sioux Falls Area Chamber of Commerce. A native of Yankton, South Dakota, Dave is a graduate of Harvard College and the New York University School of Law. He received an M.B.A. from the University of South Dakota School of Business.